Advertisement

The Bactericidal Defect of Neutrophil Function with Lithium Therapy

  • William R. Friedenberg
  • James J. Marx
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 127)

Abstract

Lithium has been promoted for the treatment of granulocytopenia and as an adjuvant for cancer chemotherapy (Jacob and Herbert, 1974; Gupta et al., 1975; Greco, 1976; Greco and Brereton, 1977; Charron et al., 1977; Tisman and Wu, 1977; Catane et al., 1977; Stein et al., 1977). In preliminary studies of 8 normal volunteers we found a significant bactericidal defect of the granulocytes when studied after 1 week of lithium therapy. We also assessed lymphocyte subpopulations, function, and cell mediated immunity both in vivo and in vitro and could find no defect of lymphocyte function except for a reduction in the response of the lymphocytes to PPD antigen. The rational for the use of lithium is to decrease the incidence of infection in patients who have granulocytopenia. With such defects demonstrated in normals after short term doses, granulocyte and lymphocyte functions were studied in patients on long term lithium therapy.

Keywords

Neutrophil Function Lymphocyte Function Myeloperoxidase Activity Lithium Therapy Phagocytic Index 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Catane, R., Kaufman, J., Mittelman, A., and Murphy, G.P., 1977, Attenuation of myelosuppression with lithium, N. Eng, J. Med. 297:452.CrossRefGoogle Scholar
  2. Charron, D., Barrett, A.J., Faille, A., Alby, N., Schmitt, T., and Degos, L., 1977, Lithium in acute myeloid leukemia, Lancet 1:1307.PubMedCrossRefGoogle Scholar
  3. Cohen, M.S., Zakhireh, B., Metcalf, J.A., and Root, R.K., 1979, Granulocyte function during lithium therapy, Blood 53:913.PubMedGoogle Scholar
  4. Dousa, T., and Hechter, O., 1970, Lithium and brain adenyl cyclase, Lancet 1:834.PubMedGoogle Scholar
  5. Ebstein, R., Belmaker, R., Grunhaus, L., and Rimon, R., 1976, Lithium inhibition of adrenalin-stimulated adenylate cyclase in humans, Nature 259:411.PubMedCrossRefGoogle Scholar
  6. Essman, W.B., 1975, Lithium, Lancet 2:547.PubMedCrossRefGoogle Scholar
  7. Forn, J., and Valdecasas, F.G., 1971, Effects of lithium on brain adenyl cyclase activity, Biochem. Pharmacol. 20:2773.PubMedCrossRefGoogle Scholar
  8. Frausto da Silva, J.J.R., and Williams, R.J.P., 1976, Possible mechanism for the biological action of lithium, Nature 263:237.CrossRefGoogle Scholar
  9. Frazer, A., Haugaard, E.S., Mendels, J., and Haugaard, N., 1975, Effects of intracellular lithium on epinephrine-induced accumulation of cyclic AMP in skeletal muscle, Biochem. Pharmacol. 24:2273.PubMedCrossRefGoogle Scholar
  10. Friedenberg, W.R., and Marx, Jr., J.J., 1979, The effect of lithium carbonate on lymphocyte, granulocyte, and platelet function, Cancer (in press).Google Scholar
  11. Greco, F.A., 1976, Lithium and leukocytosis, Ann. Int. Med. 84:102.PubMedGoogle Scholar
  12. Greco, F.A., and Brereton, H.D., 1977, Effect of lithium carbonate on the neutropenia caused by chemotherapy: A preliminary clinical trial, Oncology 34:15.CrossRefGoogle Scholar
  13. Gupta, R.C., Robinson, W.A., and Smyth, C.J., 1975, Efficacy of lithium in rheumatoid arthritis with granulocytopenia (Felty’s syndrome), Arthritis Rheum, 18:179.PubMedCrossRefGoogle Scholar
  14. Hansen, R.L., Marx, Jr., J.J., Ptacek, L.J., and Roberts, R.C., 1977, Immunologic studies on an aberrant form of ataxia telangiectasia, Am. J. Dis. Child. 131:518.PubMedGoogle Scholar
  15. Jacob, E., and Herbert, V., 1974, Lithium therapy for neutropenias, J. Clin. Invest. 53:35.Google Scholar
  16. Kaplow, L.S., 1965, Simplified myeloperoxidase stains using benzidine dihydrochloride, Blood 26:215.PubMedGoogle Scholar
  17. Park, B.H., Fikrig, S.M., and Smithwick, E.M., 1968, Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnositic aid, Lancet 2:532.PubMedCrossRefGoogle Scholar
  18. Rothstein, G., Clarkson, D.R., Larsen, W., Grosser, B.I., and Athens, J.W., 1978, Effect of lithium on neutrophil mass and production, N. Engl. J. Med. 298:178.PubMedCrossRefGoogle Scholar
  19. Rossof, A.H., and Coltman, Jr., C.A., 1976, The effect of lithium carbonate on the granulocyte phagocytic index, Experientia 32:238.PubMedCrossRefGoogle Scholar
  20. Stein, R.S., Beaman, C., Ali, M.Y., Hansen, R., Jenkins, D.D., and Jume’an, H.G., 1977, Lithium carbonate attenuation of chemotherapy-induced neu-tropenia, N. Eng. J. Med. 297:430.CrossRefGoogle Scholar
  21. Tisman, G., and Wu, S.J.G., 1977, Lithium-induced granulocytosis, Lancet 2:251.PubMedCrossRefGoogle Scholar
  22. Ward, P.A., 1976, Chemotaxis, in: “Manual of Clinical Immunology,” (N.R. Rose, and H. Friedman, eds.), p. 1109, American Society of Microbiology, Washington, DC.Google Scholar
  23. Weir, D.M., 1973, “Handbook of Experimental Immunology,” Blackwell Scientific Publication, Oxford.Google Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • William R. Friedenberg
    • 1
  • James J. Marx
    • 1
  1. 1.Marshfield Medical FoundationMarshfieldUSA

Personalised recommendations